Aims/hypothesis To determine the impact of maternal diabetes during pregnancy on racial disparities in fetal growth. Methods Using linked birth certificate, inpatient hospital and prenatal claims data we examined live singleton births of mothers resident in South Carolina who self-reported their race as non-Hispanic white (NHW; n0140,128) or nonHispanic black (NHB; n 082,492) and delivered at 28-42 weeks' gestation between 2004 and 2008. Results Prepregnancy diabetes prevalence was higher in NHB (3.0%) than in NHW (1.7%), while the prevalence of gestational diabetes mellitus (GDM) was similar in NHB (6.1%) and NHW (6.3%). At a delivery BMI of 35 kg/m 2 , GDM exposure was associated with an average birthweight only 17 g (95% CI 4, 30) higher in NHW, but 78 g (95% CI 61, 95) higher in NHB (controlling for gestational age, maternal age, infant sex and availability of information on prenatal care).
Introduction
As the incidence of diabetes continues to rise, women of childbearing age are at increased risk of diabetes during pregnancy [1] [2] [3] [4] [5] [6] [7] . The lifetime risk of diabetes among females born in the United States in 2000 was estimated to be 39%, based on information obtained from the National Health and Nutrition Examination Surveys (NHANES) conducted between 1984 and 2000 [8] . Moreover, the estimated lifetime risk of diabetes was higher for minority groups than for non-Hispanic whites (NHW) and for women compared with men [8] .
The 'fetal origin of disease' hypothesis proposes that gestational programming may critically influence adult health and disease [9] . Obesity prior to pregnancy and high weight gain during pregnancy predispose women to gestational diabetes mellitus (GDM) and early-onset type 2 diabetes [10] [11] [12] . Maternal diabetes during gestation exposes the fetus to hyperglycaemia, resulting in increased fetal insulin levels that both promote the storage of excess energy as fat and act as a growth factor. Maternal diabetes is associated with high birthweight, increased childhood and adult obesity and increased risk of type 2 diabetes [13] [14] [15] [16] [17] . Children exposed in utero to diabetes are at higher risk of obesity and diabetes compared with their unexposed siblings, suggesting that the increased risk to the exposed offspring is not exclusively genetic [18, 19] .
Maternal obesity, pregnancy weight gain and diabetes during pregnancy are modifiable risk factors that determine birthweight for gestational age during the third trimester. Macrosomic infants, large-for-gestational-age (LGA) infants and infants exposed to diabetes in utero are at increased risk of complications during delivery [20, 21] . While differences in maternal and neonatal outcomes in blacks and whites have been examined at the low end of the birthweight distribution [22] [23] [24] , few studies have focused on racial/ethnic differences in neonatal outcomes at the high end of the birthweight distribution. In a study based on US live birth data from 1990 to 1991, Kieffer et al. reported a disparity in birthweight associated with diabetes of 212 g in black infants, but only 116 g in white infants [25] . However, this study was limited in that it relied solely on birth certificatereported presence of diabetes during pregnancy at a time when diabetes was less frequently reported on the birth certificate, and no information on maternal prepregnancy weight or weight gain during pregnancy was available. Therefore, our objective was to determine the impact of maternal diabetes during pregnancy on racial disparities in birthweight for gestational age at the population level in South Carolina in 2004 to 2008.
Methods
Study design and population Live singleton births of mothers resident in South Carolina who self-reported their race as NHW or non-Hispanic black (NHB), and who delivered at a gestational age of [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] Variable definition Diabetes during pregnancy was defined either by gestational or prepregnancy diabetes reported on the birth certificate or if it was coded for on the inpatient hospital discharge records or during the prenatal period. The prenatal period was defined by the date of delivery and gestational age of the infant at delivery and additionally included the year prior to conception in defining prepregnancy diabetes. In addition, for a diagnosis of diabetes during pregnancy based on the prenatal data alone, two or more ICD-9-CM diagnostic codes indicative of diabetes were required in the medical record (www.icd9data.com/2007/ Volume1/240-279/250-259/250/default.htm). This criterion was based on a validated algorithm developed for use in the Veterans Health Administration [26] . Primary and secondary inpatient hospital and prenatal ICD-9-CM diagnosis codes used to define diabetes included those for prepregnancy and GDM (i.e. 64801-64802, 25000-25092, 64881-64882). Further classification into having prepregnancy diabetes or GDM was based on evidence of prepregnancy diabetes from any source. Hence, when one source reported prepregnancy diabetes and another reported GDM a woman was classified as having prepregnancy diabetes. Maternal hypertension during pregnancy was defined as reported on the birth certificate (i.e. either GDM or prepregnancy diabetes).
Maternal race, education (dichotomised on the basis of high school graduation or a General Educational Development Diploma), private health insurance status, firstborn (based on report of previous live births) and tobacco use were defined as reported on the birth certificate. Adequacy of prenatal care was defined based on the revised GINDEX, which combines information from the birth certificate on the trimester when prenatal care was first received and the total number of prenatal visits [27] . Birthweights inconsistent with gestational age were identified based on a modified version of the criteria published by Alexander et al. [28] : the modification allowed for a birthweight up to 6,500 g at a gestational age of 39 weeks and 7,000 g at a gestational age ≥40 weeks. Birthweights considered consistent with gestational age are as follows: 28 weeks, 250-2,500 g; 29 weeks, 250-2,750 g; 30 weeks, 375-3,000 g; 31 weeks, 375-3,250 g; 32 weeks, 500-3,500 g; 33 weeks, 500-3,750 g; 34 weeks, 750-4,000 g; 35 weeks, 750-4,500 g; 36 weeks, 750-5,000 g; 37 weeks, 1,000-5,500 g; 38 weeks, 1,000-6,000 g; 39 weeks, 1,000-6,500 g; 40 weeks, 1,000-7,000 g; 41 weeks, 1,000-7,000 g; and 42 weeks, 1,000-7,000 g.
We conducted analyses of birthweight adjusted for gestational age, representing a measure of fetal growth on a continuous scale.
LGA and small-for-gestational-age (SGA) infants were based on the 90th and 10th percentiles of weight for gestational age, respectively, according to fetal growth curves derived using a United States national reference based on births in 1999-2000 [29] . The same standard growth curve was used for NHW and NHB infants to define LGA and SGA.
Statistical analysis A series of analyses was completed with maternal race, diabetes status and maternal BMI at delivery being the exposures of interest and birthweight being the outcome of interest. Throughout all analyses gestational age and infant sex were covariates in the models; hence, birthweight was adjusted for gestational age and infant sex and was therefore a measure of fetal growth.
Linear regression using up to fourth-order polynomials when required was used to examine the relationship between race, diabetes status and birthweight. Appropriate interaction terms were used to determine whether GDM and prepregnancy diabetes impacted birthweight similarly in NHW and NHB women. In secondary analyses, we also considered gestational age as an effect modifier of the relationship between maternal diabetes and birthweight, and we considered maternal BMI at delivery as a potential effect modifier of the relationship between each type of maternal diabetes and birthweight. A p value of 0.05 was used as a nominal value for statistically significant interactions. Additionally, we used negative-binomial regression to estimate RRs in the framework of generalised linear models [30] . To deal with convergence problems we used Poisson regression with a robust variance estimator [31] as demonstrated by Spiegelman and Hertzmark [32] . Throughout these analyses appropriate interaction terms were used to determine whether race modified the effect of each type of maternal diabetes on dichotomous outcomes of interest including SGA and LGA. Sequentially built models were compared using Akaike's information criterion and the Bayesian information criterion.
Results
Of 278,438 live singleton births to mothers resident in South Carolina, reasons for exclusion included maternal race or ethnicity missing or unknown, 1,585 (0.57%); maternal race identified as other, 6,032 (2.17%); and maternal race identified as Hispanic, 26,631 (9.56%). Of the remaining 92,233 births to NHB mothers and 151,957 births to NHW mothers, reasons for exclusion included missing gestational age based on last menstrual period (LMP), 15,541 (6.36%); gestational age >42 weeks, 7,666 (3.14%); gestational age <28 weeks, 2,554 (1.05%); and birthweights inconsistent with gestational age, 1,254 (0.51%) [28] . Hence, the study population for this analysis includes 80,480 births to NHB mothers and 136,695 births to NHW mothers. Maternal inpatient hospital procedure and diagnostic codes from delivery were successfully linked for 203,699 (93.79%) births, while prenatal information was available for 114,684 (52.81%) births to mothers with Medicaid and 14,304 (6.59%) births to mothers with the State Health Plan.
The unadjusted prevalence of prepregnancy diabetes was higher in NHB (3.0%) than in NHW (1.7%), while the prevalence of GDM was similar in NHB (6.1%) and NHW (6.3%; Table 1 ). On average, maternal age was lower in NHB than in NHW, but higher in those with either prepregnancy diabetes or GDM than in those without diabetes. Mean prepregnancy BMI in NHB ranged from 28.4 kg/m Examining the relationship between gestational age and birthweight in the six strata defined by race and diabetes status, we found that infant birthweight was significantly higher in women with GDM than in women without diabetes from a gestational age of 35 through 40 weeks in NHW women and from a gestational age of 35 through 42 weeks in NHB women (Fig. 1a, b) . Similarly, infant birthweight was significantly higher in women with prepregnancy diabetes than in women without diabetes from a gestational age of 35 through 39 weeks in NHW women and 34 through 42 weeks in NHB women. Moreover, from a gestational age of 36 weeks through 42 weeks, when over 85% of births occur, the impact of GDM on birthweight was higher in NHB than in NHW. By contrast, the impact of prepregnancy diabetes on birthweight was only higher in NHB than in NHW from a gestational age of 40 through 42 weeks. For example, at 38 weeks, exposure to GDM in utero was associated on average with birthweights 97 g (95% CI 84, 109) higher in NHW and 157 g (95% CI 141, 174) higher in NHB after controlling for maternal age, infant sex and whether information from the mother's prenatal medical record was available ( Table 2 , Model 1). Parallel numbers for prepregnancy diabetes were 183 g (95% CI 160, 205) in NHW and 185 g (95% CI 162, 208) in NHB. Hence, GDM had a greater impact on birthweight in NHB infants than in NHW infants (61 g racial difference [95% CI 40, 81]), while prepregnancy diabetes had a large but similar effect on NHW and NHB infants (non-statistically significant 2 g racial difference). Further adjustment for maternal BMI at delivery slightly attenuated the racial difference associated with GDM (51 g [95% CI 31, 72]); however, further adjustment for maternal tobacco use, hypertension, education and prenatal care as well as whether an infant was firstborn had little effect on racial differences ( Table 2 , Models 2 and 3, respectively).
Looking at BMI, we found that in NHW and NHB women, as maternal BMI increased at delivery, the impact of GDM and prepregnancy diabetes on infant birthweight increased ( Fig. 2) . Birthweight was higher in women with GDM than in women without diabetes at a delivery BMI of ≥34 kg/m 2 in NHW and at a delivery BMI of ≥28 kg/m 2 in NHB. Birthweight was higher in women with prepregnancy diabetes than in women without diabetes when delivery BMI reached ≥26 kg/m 2 in NHW and when delivery BMI reached ≥29 kg/m 2 in NHB. The impact of diabetes on birthweight was significantly greater in NHB than in NHW when delivery BMI reached ≥28 kg/m 2 for GDM, but was similar in NHB and NHW women with prepregnancy diabetes. At a delivery BMI of 35 kg/m 2 , exposure to GDM was associated with an average birthweight 17 g (95% CI 4, 30) higher in NHW and 78 g (95% CI 61, 95) higher in NHB after controlling for gestational age, maternal age, infant sex and availability of prenatal care information (Table 3 , Model 1). Parallel numbers for prepregnancy diabetes were 58 g (95% CI 34, 81) in NHW and 60 g (95% CI 37, 84) in NHB. Hence, GDM had a greater impact on birthweight in NHB infants than in NHW infants (60 g racial difference [95% CI 39, 82]), while prepregnancy diabetes had a large but similar effect on NHW and NHB infants (non-statistically significant 3 g racial difference). Further adjustment for maternal tobacco use, hypertension, education and prenatal care as well as whether an infant was firstborn had little effect on racial differences for either GDM or prepregnancy diabetes (Table 3 , Model 2).
The prevalence of having an LGA infant was highest in women with prepregnancy diabetes (NHW, 19.3%; NHB, 12.1%) and lowest in women without diabetes (NHW, 9.2%; NHB, 3.8%; Table 4 ). After adjusting for demographic factors (maternal age, infant sex) and the availability of prenatal diagnostic codes, the risk of having an LGA infant relative to an infant with normal weight for gestational age (NGA) associated with GDM was 41% higher in NHW (RR Table 5 ). Additional adjustment for maternal BMI at delivery attenuated the RRs associated with having an LGA infant somewhat; however, adjusting for maternal education level, Medicaid status and pregnancy risk factors (firstborn, tobacco use, diabetes status and hypertension status, as well as prenatal care as defined by the revised GINDEX) did not further attenuate the increased risk associated with GDM or prepregnancy diabetes of having an LGA infant in NHW or NHB women. When the outcome was SGA, the risk associated with GDM and prepregnancy diabetes was marginal in NHW and NHB women (Table 5) .
Discussion
In the majority of births to NHW and NHB women, GDM, prepregnancy diabetes and obesity were associated with increased fetal growth as measured by birthweight. Moreover, while the impact of GDM on birthweight was greater in NHB than in NHW, the impact of prepregnancy diabetes was similar in NHB and NHW for the majority of births. Interestingly, in NHW women prepregnancy diabetes had a greater impact on infant birthweight than did GDM, while in NHB women prepregnancy diabetes and GDM had a similar impact on infant birthweight. In NHW infants GDM did not have a statistically significant impact on infant birthweight until maternal delivery BMI reached 34 kg/m 2 . By contrast, in NHB women GDM impacted infant birthweight at a maternal delivery BMI of 28 kg/m 2 . As maternal BMI at delivery increased, the differential impact of GDM on birthweight between NHW and NHB infants increased, while the impact of prepregnancy diabetes on birthweight was similar in NHW and NHB infants across the spectrum of maternal BMI.
Our results are consistent with recent results from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study which reported that hyperglycaemia below levels diagnostic of GDM [33] and maternal BMI at the time of the OGTT [34, 35] were each independently and positively associated with birthweight >90th percentile, with the association for each exposure being continuous and graded. While the HAPO study did not find evidence of interaction between maternal BMI at the time of the OGTT and glycaemia in relation to birthweight >90th percentile [33] , the investigators' analysis and a priori focus was not to examine whether maternal BMI modified the relationship between hyperglycaemia and birthweight; hence, their analysis, which used categorical variables for BMI, hyperglycaemia and the birthweight outcome, was not optimal to identify an interaction. Moreover, the magnitude of the racial difference of the impact of GDM on infant birthweight in our study, which was 60 g (95% CI 39, 82) at a maternal BMI at delivery of 35 Table 2 intervention studies which suggest that treatment of mild GDM can reduce birthweight by 100-140 g [36, 37] .
Strengths of previous relevant clinical studies include accurate ascertainment of maternal diabetes status and detailed information on patient characteristics [38] [39] [40] [41] . In 2004 the South Carolina birth certificate was revised to improve the quality of data collected relating to maternal diabetes and obesity. Specifically, check boxes were added to differentiate between gestational and established diabetes; and information on maternal height, prepregnancy weight and weight at delivery Table 2 Adjusted birthweights (g) and birthweight differences (95% CI) at a gestational age of 38 and 40 weeks, stratified by race and diabetes status a Model 1 is specified in Fig. 1 a, Table 3 was added. Moreover, a validation study was conducted on a population-based sample of 4,541 women who had live births in 2000 in Washington State, which uses a birth certificate comparable to the South Carolina birth certificate [42] . The reported true-positive fraction combining information across the birth certificate with hospital discharge data and using medical record review as the gold standard was 93.3 (95% CI 86.9, 99.7) for GDM and 96.9 (95% CI 91.6, 100) for established diabetes in the validation study [42] .
Respective false-positive fractions were 0.9 (95% CI 0.5, 1.4) and 0.5 (95% CI 0, 1.1) [42] . In the current study, diagnostic codes were available during the prenatal period for 58.5% of births. Among individuals receiving prenatal care through Medicaid, the prevalence of any type of diabetes during pregnancy was 7.2% based on the Washington State diabetes criteria and increased to 8.4% when information from prenatal care was incorporated which required at least two diagnostic codes indicative of diabetes for a positive diabetes classification. The Washington State validation study indicated that combining information across multiple sources provided the best definition of diabetes during pregnancy [42] ; hence, we opted to be inclusive in our definition of diabetes during pregnancy.
The prevalence of identified diabetes during pregnancy of 9.1% in NHB and 8.1% in NHW are on the high end of current estimates of diabetes during pregnancy, which range from 2% to 10% of pregnancies in the United States, with estimates being higher for racial and ethnic minority groups than for NHW groups [43] . Notably, the prevalence of LGA, large for gestational age; PPDM, prepregnancy diabetes; SGA, small for gestational age identified diabetes during pregnancy in the current study is considerably higher than that reported in the national population-based study using data on live births from 1990 to 1991, which reported a prevalence of diabetes during pregnancy of 2.26% in NHB and 1.98% in NHW [25] . Prior population-based studies of racial disparities of the impact of diabetes on birthweight have not incorporated information on maternal weight or type of diabetes (i.e. prepregnancy or gestational). Moreover, maternal weight and maternal weight gain are associated with increased birthweight [44, 45] . Hence, we sought to examine the extent to which obesity modified the effect of diabetes on birthweight. We focused on maternal BMI at delivery because it incorporated information on maternal prepregnancy weight as well as maternal weight gain during pregnancy. The quality of data on diabetes status, which includes the subdivision by GDM or prepregnancy diabetes, is impacted not only by reporting, coding and screening practices (both before and during pregnancy) but also by whether or not we had information on prenatal care from either the State Health Plan or Medicaid, all of which may be differential with respect to race. In our study, use of Medicaid was higher in NHB (73.3%) than in NHW (40.8%); hence, ascertainment of diabetes during pregnancy may be more complete in NHB than in NHW. On the other hand, because Medicaid eligibility is dependent on need, and eligibility increases during pregnancy, individuals with private insurance may receive better care prior to pregnancy. Moreover, screening, diagnosis and treatment practices for diabetes during pregnancy likely varied across the state from one doctor's office to another. In this study the prevalence of prepregnancy diabetes (3.0% vs 1.7%) was higher in NHB than in NHW women, while the prevalence of GDM was similar in NHW and NHB women (6.3 vs 6.1%). We elected to classify individuals as having prepregnancy diabetes rather than GDM if information from any source reported prepregnancy diabetes. As a result, 41.5% of NHB women and 44.5% of NHW women with a classification of prepregnancy diabetes also had GDM reported on their birth certificate, hospital discharge record or prenatal record. Our prevalence estimates for prepregnancy diabetes and GDM are consistent with results from a study of the Kaiser Permanente managed healthcare programme in Southern California which reports 2005 prevalence estimates for prepregnancy diabetes of 1.5% in NHW and 2.6% in NHB, and prevalence estimates for GDM of 5.3% in NHW and 5.0% in NHB [46] .
Type of diabetes may be important because women with prepregnancy diabetes are at risk of adverse pregnancy outcomes starting in the periconceptional period, while risks associated with GDM usually develop in the second trimester. Among those with diabetes the prevalence of prepregnancy diabetes was higher in NHB than in NHW (32.8% vs 21.5%). Interestingly, the impact of prepregnancy diabetes on infant birthweight appears similar in NHW and NHB women. However, in NHB women, infant birthweight is similar in those with GDM or prepregnancy diabetes; while in NHW women, infant birthweight is higher in those with prepregnancy diabetes than in those with GDM, resulting in a differential impact of GDM on birthweight by race. Potential explanations for these findings are that a higher percentage of NHB women with GDM than NHW women with GDM actually had undiagnosed diabetes prior to pregnancy, that diabetes with onset during pregnancy is actually more severe in NHB than in NHW women, or that treatment (or response to treatment) for GDM is poorer in NHB than in NHW women. The prevalence of intensive prenatal care as defined by the revised GINDEX was higher in NHB women with GDM (26.0%) than in NHW women with GDM (22.0%). However, NHW women with GDM were much more likely to report private health insurance than were NHB women with GDM (57.4% vs 28.2%, respectively), which may indicate more comprehensive healthcare prior to pregnancy in NHW than in NHB women. A surveillance study of diabetes in youth estimated the prevalence of type 1 diabetes to be lower and the prevalence of type 2 diabetes to be higher in NHB teenagers than in NHW teenagers [47] .
One study limitation is that we did not have information on treatment received for diabetes during pregnancy-an important factor because tight control of glucose levels during pregnancy impacts infant birthweight [36, 37] . A second limitation of our study is the use of administrative databases and the reliability of data obtained from these databases. For instance, the quality of data available differentiating between prepregnancy and GDM, as well as our inability to discriminate between type 1 and type 2 diabetes, prevented us from completing an exhaustive analysis of the impact of diabetes type on racial differences in outcomes. Hence, differential diagnosis, treatment and severity of diabetes during pregnancy may be explanations for the greater impact of GDM on birthweight in NHB relative to NHW which we were unable to assess. Finally, the use of LMP to calculate gestational age has limitations [48] which may be differential with respect to diabetes status, given the association between diabetes and irregular menses [49, 50] ; however, because birthweight, our outcome, may differentially impact the clinical/obstetric estimate of gestational age we relied on LMP to calculate gestational age.
Our study provides evidence that GDM has a greater impact on birthweight in NHB infants than in NHW infants, and that this disparity increases with increasing maternal BMI. In NHW infants, GDM appears only to impact birthweight when maternal delivery BMI is ≥34 kg/m 2 , which is relatively high. By contrast, in NHB infants, GDM appears to impact birthweight starting at a much lower maternal delivery BMI of 28 kg/m 2 . Interestingly, for the vast majority of births, prepregnancy diabetes appears to have a similar impact on birthweight in NHB and NHW infants. Because the prevalence of diabetes is quite high in our study (9.1% in NHB and 8.1% in NHW), even a small shift in birthweight is likely to have a large impact at the population level. Further research is warranted to understand the impact of maternal diabetes and obesity during pregnancy on racial health disparities.
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